Check out this week's QuadCast as we highlight shorter duration trastuzumab for breast cancer, reduced length ADT in prostate cancer patients receiving brachy boost, head & neck location as a high risk factor in Merkel cell carcinoma, and more.
Check out this week's QuadCast as we highlight shorter duration trastuzumab for breast cancer, reduced length ADT in prostate cancer patients receiving brachy boost, head & neck location as a high risk factor in Merkel cell carcinoma, and more.